Safety and Feasibility of the Artificial Vascular Graft for Hepatic Outflow Reconstruction in Living Donor Liver Transplantation
Daisuke Nobuoka(Fukuyama City Hospital), Takahito Yagi(Okayama University), Daisuke Satoh(Okayama University), Masashi Utsumi(Okayama University), S. Shinoura(Okayama University), Y. Umeda(Kyoto University), H. Sadamori(Okayama University), T Fujiwara(Okayama University), Ryusuke Yoshida(Okayama University)
Cited by 0
Related Papers
Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
|Clinical Cancer Research|2012|304
Abnormal Taste Perception in Mice Lacking the Type 3 Inositol 1,4,5-Trisphosphate Receptor
|Journal of Biological Chemistry|2007|178
Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients
|OncoImmunology|2016|178
Risk factors for major morbidity after liver resection for hepatocellular carcinoma
|British journal of surgery|2012|104